Genomics Editing Market Has Vast Growth Prospects Impacted By Increasing Government Funding & Growing Application Areas Of Genomics.

Global Genome Editing Market Projected to Grow at a CAGR of 13.2% over the Forecast Period 2017-2025

Genome editing market is propelled by number of factors such as increasing government funding for genome projects, technological advancement, high prevalence of cancer & other infectious diseases. According to Goldstein Research, global genome editing market size is expected to reach USD 8.56 billion by 2025, growing at a compounded annual growth rate of 13.2% during the forecast period 2017-2025. Moreover, the growth of global genomics market has direct implications, which is growing at a CAGR of 11.2% during the forecast period.

Global genome editing market segmentation has been carried out on the basis of technology, application, end user and geography. On the basis of technology, CRISPR segment accounted for largest market share of 45% in 2017. Whereas, based on application, cell line engineering segment in 2017 is leading the genome engineering market.

Further, Global genome editing industry is estimated to be dominated by North America with a market share of 35.25% in 2017. Whereas, Asia Pacific region is expected to be most opportunistic & fastest developing region for the growth of genome editing industry due to increasing government focus on the field of genomics. Further, Europe accounts for substantial market share due to presence of key players in the region.

Market Segmentation

On the basis of our in-depth analysis, Global Genome Editing Market can be segmented as follows:

  • By Technology
    • CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats)
    • TALEN
    • ZFN
    • Other ((PiggyBac, Flp-In, Adenine Base Editor (ADE), Antisense and Jump-In)
  • By Application
    • Cell Line Engineering
    • Animal Genetic Engineering
    • Plant Genetic Engineering
  • By End User
    • Biotechnology & Pharmaceutical Companies
    • CROs
  • By Region
    • North America (US, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
    • Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
    • Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
    • Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
    • Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
    • Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}

Download Exclusive Sample Report:


 “Global Genome Editing Market Outlook 2025” contains detailed overview of the global genome editing market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by technology, application and end user.

Further, for the in-depth analysis, Genome Editing Market Report encompasses the market growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis.

 This market research report also includes competitive outlook of some of the major players profiling of companies such as Horizon Discovery Group plc, Thermo Fisher Scientific, Merck, Horizon Discovery Group, GenScript, Sangamo BioSciences, Integrated DNA Technologies, Lonza Group, New England Biolabs, OriGene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, CRISPR Therapeutics, etc.

The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the report represents the global genome editing market trends along with market forecast that will help market consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on Healthcare Industry Analysis reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.

Media Contact
Company Name: Goldstein Research
Contact Person: Steve Blade
Email: Send Email
Phone: +1-6465687747
Address:99 Wall Street, Suite No:- 527
City: New York
State: NY
Country: United States